Iridium Communications Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Iridium Communications Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $871.66M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $830.68M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $790.72M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $721.03M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $614.50M | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $146.51M | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | $151.47M | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | $140.17M | Mar 31, 2021 |
| FY2020 | Mar 31, 2020 | $145.29M | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $138.87M | Mar 31, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $871.66M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $830.68M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $790.72M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $721.03M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $614.50M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $583.44M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $560.44M | Feb 17, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $115.47M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $116.55M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $111.60M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $104.43M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $107.45M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $112.79M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $109.20M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $104.20M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $106.42M | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $106.03M | Feb 23, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.37M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $112.78M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $15.42M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $8.72M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | ($9.32M) | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | ($7.93M) | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | ($4.01M) | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | ($12.42M) | Mar 31, 2021 |
| FY2020 | Mar 31, 2020 | ($31.70M) | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | ($107.86M) | Mar 31, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $235.98M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $200.38M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $81.63M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $76.68M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $46.31M | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $5.10M | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | $12.73M | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | $5.83M | Mar 31, 2021 |
| FY2020 | Mar 31, 2020 | $11.82M | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $1.0K | Mar 31, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.76M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $28.42M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $20.27M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $16.22M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $11.89M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $12.04M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $14.31M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $22.43M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $15.25M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $16.08M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $157.71M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $168.18M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $143.71M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $123.50M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $100.47M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $90.05M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $93.17M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $97.85M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $84.41M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $82.55M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $400.07M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $375.96M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $314.91M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $344.73M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $302.87M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $249.77M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $198.14M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $263.71M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $259.62M | Feb 25, 2020 |
| FY2012 | Dec 31, 2012 | $174.02M | Mar 5, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.28M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $69.89M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $73.49M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $71.27M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $42.15M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $38.69M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $117.82M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $391.39M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $400.11M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $405.69M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.67B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.66B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $2.95B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $3.18B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $3.36B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $3.62B | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $4.01B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $3.78B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $3.50B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.09B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.77B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.83B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.89B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.94B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.16B | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.41B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $2.19B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.16B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $462.60M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $576.64M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $888.10M | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $1.13B | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $1.29B | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | $1.42B | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | $1.46B | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | $1.60B | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $1.60B | Mar 31, 2021 |
| FY2019 | Dec 31, 2016 | $1.34B | Feb 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $98.94M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $98.19M | Feb 12, 2026 |
| FY2024 | Apr 1, 2024 | $98.19M | Feb 13, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Feb 13, 2025 |
| FY2018 | Dec 31, 2017 | $0 | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $0 | Feb 23, 2017 |
| FY2015 | Dec 31, 2014 | $87.04M | Feb 25, 2016 |
| FY2014 | Dec 31, 2013 | $87.04M | Feb 26, 2015 |
| FY2013 | Dec 31, 2012 | $87.04M | Mar 4, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($418.55M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | ($406.09M) | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | ($235.40M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | ($47.74M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $140.81M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $275.92M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $331.97M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $501.71M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $518.79M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $288.80M | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.50M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $93.53M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $71.87M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $168.77M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $320.91M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $237.18M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $223.56M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $273.35M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $285.87M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $371.17M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.76B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.47B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.47B | Feb 15, 2024 |
| FY2021 | Dec 31, 2021 | $1.58B | Feb 17, 2022 |
| FY2020 | Dec 31, 2020 | $1.60B | Mar 31, 2021 |
| FY2019 | Dec 31, 2019 | $1.77B | Feb 25, 2020 |
| FY2018 | Dec 31, 2018 | $1.83B | Feb 28, 2019 |
| FY2017 | Dec 31, 2017 | $1.62B | Feb 22, 2018 |
| FY2016 | Dec 31, 2016 | $1.80B | Feb 23, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 13, 2025 |
| FY2019 | Dec 31, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 25, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 110.36M | Feb 13, 2025 |
| FY2024 | Dec 31, 2023 | 122.78M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 125.90M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | 131.34M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | 134.06M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 131.63M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 112.20M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 98.20M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 95.88M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | 95.13M | Feb 23, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.85M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $64.74M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $64.77M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $0 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Feb 15, 2024 |